Tobramycin Variants with Enhanced Ribosome-Targeting Activity

Chembiochem. 2015 Jul 27;16(11):1565-70. doi: 10.1002/cbic.201500256. Epub 2015 Jun 17.

Abstract

With the increased evolution of aminoglycoside (AG)-resistant bacterial strains, the need to develop AGs with 1) enhanced antimicrobial activity, 2) the ability to evade resistance mechanisms, and 3) the capability of targeting the ribosome with higher efficiency is more and more pressing. The chemical derivatization of the naturally occurring tobramycin (TOB) by attachment of 37 different thioether groups at the 6''-position led to the identification of generally poorer substrates of TOB-targeting AG-modifying enzymes (AMEs). Thirteen of these displayed better antibacterial activity than the parent TOB while retaining ribosome-targeting specificity. Analysis of these compounds in vitro shed light on the mechanism by which they act and revealed three with clearly enhanced ribosome-targeting activity.

Keywords: aminoglycoside; antibacterial agents; bacterial resistance; drug-modifying enzymes; translocation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Escherichia coli / cytology
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology
  • Ribosomes / drug effects*
  • Tobramycin / chemistry*
  • Tobramycin / metabolism
  • Tobramycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Tobramycin